Pf Magazine August 2018

What's next for field sales?

Pf Magazine July 2018

Market Access Special Edition

Pf Magazine June 2018

The NHS turns 70

Pf Awards May 2018

Post Awards Brochure

Pf Magazine April 2018

The biggest Pf Awards yet

Pf Magazine March 2018

Pharma millennials

Pf Magazine February 2018

Meds & mindfulness

Pf Magazine January 2018

The year ahead in pharma

Pf Magazine December 2017

The year that was in pharma

Pf Magazine November 2017

Rise of the digital doctor

Latest articles

IMBRUVICA® misses primary endpoint in pancreatic cancer trial

IMBRUVICA® misses primary endpoint in pancreatic cancer trial

AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer.  AbbVie, a research-based global biopharmaceutical company,...
Star Europe reports positive client and candidate feedback.

Star Europe’s Amsterdam office off to positive start

Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
ORKAMBI® for cystic fibrosis

EC approves Vertex’s ORKAMBI® for cystic fibrosis patients

Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients.  The European Commission has granted approval...